Kerr, JR. Penicillin allergy: a study of incidence as reported by patients. Brit J Clin Pract 1994;48:5–7.
Attia, MS, Stringer, MD, McClean, P, Prasad, KR. The reduced left lateral segment in pediatric liver transplantation: an alternative to the monosegment graft. Pediatr Transplant 2008;12:696–700.
MacLaughlin, EJ, Saseen, JJ, Malone, DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med 2000;9:722–726.
Alsultan, A, Peloquin, CA. Therapeutic drug monitoring in the treatment of tuberculosis: an update. Drugs 2014;74:839–854.
Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70:195–283.
Sandora, TJ, Fung, M, Melvin, P, Graham, DA, Rangel, SJ. National variability and appropriateness of surgical antibiotic prophylaxis in US children’s hospitals. JAMA Pediatr 2016;170:570–576.
7. National Expert Panel of the ICD-9-CM Adverse Event Classification, Utah/Missouri Patient Safety Consortium. The ICD-9-CM adverse event classification. Utah Department of Health website. health.utah.gov/psi/icd9.htm. Accessed June 25, 2018.
8. Goldman, JL, Sandritter, TL, Sullins, A, Leeder, JS, Lowry, JA. Pediatric pharmacovigilance: enhancing adverse drug reaction reporting in a tertiary care children’s hospital. Ther Innov Regulat Sci 2013;47:566–571.
Beltran, RJ, Kako, H, Chovanec, T, Ramesh, A, Bissonnette, B, Tobias, JD. Penicillin allergy and surgical prophylaxis: cephalosporin cross-reactivity risk in a pediatric tertiary care center. J Pediatr Surg 2015;50:856–859.
Albertson, TE, Chenoweth, JA, Colby, DK, Sutter, ME. The changing drug culture: use and misuse of appearance- and performance-enhancing drugs. FP Essent 2016;441:30–43.
11. Hougland, P, Nebeker, J, Pickard, S, et al. Using ICD-9-CM codes in hospital claims data to detect adverse events in patient safety surveillance. In: Henriksen K, Battles JB, Keyes MA, et al., editors. Advances in Patient Safety: New Directions and Alternative Approaches, Vol. 1: Assessment. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
Hougland, P, Xu, W, Pickard, S, Masheter, C, Williams, SD. Performance of International Classification of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system. Med Care 2006;44:629–636.